... have been contaminated with a foreign molecule from mice.

A report released by researchers at the University of California-San Diego and the Salk Institute for Biological Studies says all the human embryonic stem-cell lines approved for use in federally funded research are contaminated with a foreign molecule from mice that may make them risky for use in medical therapies. It puts a kink in the Bush administration's policy that provides funding only for research using embryonic stem-cell lines created before August 2001. And it adds impetus to projects aimed at getting around that roadblock, like the California Institute for Regenerative Medicine, created by California voters in November.

http://www.siliconvalley.com/mld/siliconva...al/10720914.htm

This would be a great idea for a sci-fi horror flick, like "The Fly".

A scientists, who has been diagnosed with Alzheimer disease injects himself with an experimental stem-cell treatment, and finds he is cured of all the Alzheimer’s symptoms, but then he begins to morph into a giant mouse....

Maybe not a horror flick, this could be the beginning of another super-hero like Spiderman!

Mighty Mouse... the Movie!

Forget I wrote this here, I'm sending the idea on to Steven Spielberg.

But Steven Spielberg already produced "Pinky and the Brain" which featured an experimental mouse who became a super genius.

Perhaps that too will happen? After years of trial and error, scientists have coaxed human embryonic stem cells to become spinal motor neurons, critical nervous system pathways that relay messages from the brain to the rest of the body:

http://www.eurekalert.org/pub_releases/200...w-wsg012605.php

Moving Stem Cells Front and Center
http://www.nytimes.com/2005/02/23/business...JFH3PmI6/JpNH1A

Hans S. Keirstead might be the Pied Piper of stem cells - and not just because he makes rats walk....has been making paralyzed rats walk again, using a treatment based on human embryonic stem cells. Next year he and his corporate partner, Geron, plan to try treating people who have recent spinal cord injuries, in what would almost certainly be the first human trial of any therapy derived from such cells.